humanitarian Archived signal Translated · Українська · 2–5m lag

Звіт про людські ліки (EPAR): DuoPlavin, grapdogrel,aceylsalsalicicicous кислота, Дата авторизації: 14/03/2010, модифікація: 32, Стан: авторство

Звіт про лікування людських ліків (EPAR): Zumrad, Sasanlimab, status: application Remote

Reported by EMA What Is New
Read the complete report at EMA What Is New
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

6 reports · 2 sources

EMA What Is NewЗвіт про людські ліки (EPAR): DuoPlavin, grapdogrel,aceylsalsalicicicous кислота, Дата авторизації: 14/03/2010, модифікація: 32, Стан: авторствоEMA What Is NewЗвіт про людські ліки (EPAR): DuoPlavin, grapdogrel,aceylsalsalicicicous кислота, Дата авторизації: 14/03/2010, модифікація: 32, Стан: авторствоEMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Revision: 1, Status: Authorised
INCIDENT EVOLUTION

4 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.